2009 Midyear Clinical Meeting
Click here to go to the previous page
From Research to Clinical Practice: Pharmacogenomics Principles and Concepts
Track:
Educational Sessions (CE)
Program Code: 221-L04
Date: Monday, December 7, 2009
Time: 4:00 PM to 5:00 PM EST
Location:
Palazzo M, Level 5
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Grace Kuo,
PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine,
University of California, San Diego
Dr. Kuo is Associate Professor of Clinical Pharmacy in the Skaggs School of Pharmacy and Pharmaceutical Sciences and Associate Adjunct Professor of Family and Preventive Medicine at the School of Medicine at UCSD. She serves as the Director of San Diego Pharmacist Resource and Research Network and the Director of the American College of Clinical Pharmacy Practice-Based Research Network.
Before pursuing a career in clinical pharmacy, Dr. Kuo received her undergraduate degree in psychobiology at UCLA. After receiving her pharmacy degrees from the Massachusetts College of Pharmacy and Oregon State University/Oregon Health Sciences University, she completed postdoctoral training at the W. G. Magnuson Clinical Center at the National Institutes of Health (NIH) in Bethesda, Maryland. Dr. Kuo also received a master of public health degree in health promotion and health education from the University of Texas.
Dr. Kuos research focuses on medication safety in the ambulatory care setting. She has received federal research funding from the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Centers for Disease Control and Prevention (CDC). Her research includes studying the effects of electronic medical records and patients health literacy on medication safety. She has a clinical scientist development award to evaluate the best practices for safe use of medications in the primary care setting. In addition, she is collaborating with other clinicians, educators, and researchers to start a shared curriculum related to pharmacogenomics education.
|
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Grace Kuo,
PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine,
University of California, San Diego
Dr. Kuo is Associate Professor of Clinical Pharmacy in the Skaggs School of Pharmacy and Pharmaceutical Sciences and Associate Adjunct Professor of Family and Preventive Medicine at the School of Medicine at UCSD. She serves as the Director of San Diego Pharmacist Resource and Research Network and the Director of the American College of Clinical Pharmacy Practice-Based Research Network.
Before pursuing a career in clinical pharmacy, Dr. Kuo received her undergraduate degree in psychobiology at UCLA. After receiving her pharmacy degrees from the Massachusetts College of Pharmacy and Oregon State University/Oregon Health Sciences University, she completed postdoctoral training at the W. G. Magnuson Clinical Center at the National Institutes of Health (NIH) in Bethesda, Maryland. Dr. Kuo also received a master of public health degree in health promotion and health education from the University of Texas.
Dr. Kuos research focuses on medication safety in the ambulatory care setting. She has received federal research funding from the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Centers for Disease Control and Prevention (CDC). Her research includes studying the effects of electronic medical records and patients health literacy on medication safety. She has a clinical scientist development award to evaluate the best practices for safe use of medications in the primary care setting. In addition, she is collaborating with other clinicians, educators, and researchers to start a shared curriculum related to pharmacogenomics education.
|
Howard McLeod,
PharmD, Fred N. Eshelman Distinguished Professor and Director, Institute for Pharmacogenomics and Individualized Therapy,
The University of North Carolina
Dr Howard McLeod is Fred N. Eshelman Distinguished Professor and Director, UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill. Dr McLeod holds appointments in the Schools of Pharmacy and Medicine and the Lineberger Cancer Center. Dr McLeod is also the Principal Investigator for the CREATE Pharmacogenetics Research Network, a member of the NIH funded Pharmacogenetics Research Network and is a member of the FDA committee on Clinical Pharmacology. He also directs the Pharmacogenetics for Every Nation Initiative, which aims to help developing countries use genetic information to improve National Drug Formulary decisions. Howard has published over 350 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to integrate genetics principles into clinical practice to advance individualized medicine.
|
Description
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists Taskforce on Science
ACPE Activity #204-000-09-221-L04P
1.0 Contact Hour / Knowledge-based
Educational Content: Level 2
Moderator: Grace M. Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla
Presenter: Howard McLeod, PharmD, Fred N. Eshelman Distinguished Professor and Director, Institute for Pharmacogenomics and Individualized Therapy, The University of North Carolina, Chapel Hill, NC
Learning Objectives:
LEARNER OUTCOMES:
- Describe and define pharmacogenomic concepts and taxonomy.
- Describe pharmacogenomic principles and the effect on pharmacodynamics.
- Describe pharmacogenomic principles and the effect on pharmacokinetics.
- Identify resource databases for obtaining current and updated pharmacogenomic data and information.
- Identify the key advances that have been made in the Human Genome Project.